ENTITY
Roche Holding

Roche Holding (RO SE)

65
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
•23 Mar 2020 06:45

🇯🇵 JAPAN MARKET UPDATE • Hit the BoJ Bid and Wait for the Absolute Value Opportunity

TAKE PROFITS - Japanese equities, as measured by the TOPIX Index, rose by 1.7% over the last week in Yen terms and fell by only 0.86% in US...

Logo
542 Views
Share
•17 Jun 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

June brought renewed divergence across European ord/pref pairs. Structural outliers widened, convergence became more selective, and implementation...

Share
•02 Mar 2020 11:08

🇯🇵 JAPAN • March Company Relative Price Scores - Playing the Extremes

 • RELATIVE PRICE SCORE - COMPANIES • RELATIVE PRICE SCORE OUTLIERS - The Relative Price Score (RPS) is a measure of price performance relative to...

Logo
490 Views
Share
bearish•HJ Science
•15 Jun 2026 08:30

HJ Science IPO: Late Move in Crowded Market Dampens Future Growth Prospect

HJ Science has launched its HK IPO consisting of 14M H shares at HK$81.80 per share to fund ongoing and planned R&D activities for pipeline...

Logo
140 Views
Share
•30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
734 Views
Share
x